Anika Therapeutics | ANIK - Чистый доход





Чистый доход Изменить Дата
Abbott USD 928M 149M 2026-06
Agenus USD 39.17M 49.8M 2026-03
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD -194.28M 61.55M 2026-06
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Halozyme Therapeutics USD 229.91M 79.86M 2026-06
Heron Therapeutics USD -2.95M 14.54M 2025-12
Insmed USD -13.24M 150.32M 2026-06
Integra LifeSciences USD 4.48M 9.1M 2026-06
J&J USD 5.53B 299M 2026-06
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
Ligand Pharmaceuticals USD 48.51M 61.85M 2026-06
MacroGenics USD -36.77M 22.62M 2026-03
Merit Medical Systems USD 41M 2.99M 2026-03
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR 343M 1.27B 2026-06
Smith & Nephew USD 303M 10M 2026-06
Stryker USD 1.28B 531M 2026-06
Veracyte USD 25.49M 3.22M 2026-06
Xencor USD -21.73M 107.19M 2026-06
Zimmer Biomet Holdings USD 198.3M 39.8M 2026-06